The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.
SurvivorNet on MSN
FDA Approves New Subcutaneous (Under-the-Skin) Option for Keytruda: What It Means for Cancer Patients
The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option for patients. The subcutaneous form of Keytruda showed to deliver the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback